Clinical Trial Details

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

Categories (click each to see list of all clinical trials associated with that category): Breast (ONC)

Current Status: Open

Phase: III

Principal Investigator: Krishnamurthy, Jairam

Contact Information:
Shara Graalfs
+1 402-596-3151
shara.graalfs@unmc.edu

Eligibility: https://clinicaltrials.gov/study/NCT04961996?term=NCT04961996&rank=1

Summary
Primary Objective: The primary objective is to demonstrate superiority of the giredestrant over the control treatment. Secondary Ojectives:To evaluate the efficacy of giredestrant compared with TPC. -To evaluate the safety of giredestra